Enteragam

Quick links to important sections

Enteragam

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Enteragam

Quick Facts

Property Description
Active Ingredient Serum-derived Bovine Immunoglobulin / Protein Isolate (SBI)
Form Powder for Oral Suspension
Pharmacological Class Immunoglobulin-based therapy, Enteric protein concentrate
Common Use Specialized nutritional support for chronic intestinal health issues
Origin Biologic/Derived (bovine source)

What is Enteragam and Its Official Classification?

Enteragam is a unique, prescription-only product officially designated as an Oral Medical Food. This classification indicates that the product is formulated for the clinical dietary management of a disease or condition that requires specific nutritional support that cannot be met through diet modification alone. It is functionally classified as an enteric protein concentrate and represents a form of Immunoglobulin-based therapy.


Composition and Source: Serum-Derived Bovine Immunoglobulin (SBI)

The core functional component of Enteragam is Serum-derived Bovine Immunoglobulin / Protein Isolate (SBI), a highly purified protein concentrate derived from bovine serum. This isolate is rich in protective Immunoglobulin G (IgG), the predominant fraction, along with IgA and IgM. It is supplied as a powder for oral suspension, intended to be mixed with liquid or soft food for oral intake. This concentrated composition is designed to deliver specific factors directly to the gastrointestinal tract.


General Purpose: Non-Systemic Support for Gut Barrier Integrity

The general purpose of Enteragam is to provide specialized nutritional support for chronic intestinal issues associated with persistent loose stools. The immunoglobulins it contains function as a non-systemic agent, acting solely within the lumen of the digestive tract. Research indicates that this mechanism supports the integrity of the gut mucosal barrier by binding and neutralizing disruptive luminal factors, which helps to stabilize chronic intestinal discomfort.

Regulatory References

  1. Immunoglobulin - StatPearls - NCBI Bookshelf

What side effects are possible with Enteragam?

Possible Side Effects and Safety Information

The safety profile of Enteragam, which is an enteric protein concentrate, is primarily non-systemic, meaning its effects are largely confined to the digestive tract, consistent with its action in the gut lumen. The following information is based on classifications detailed in official regulatory documents.

Documented Adverse Reactions

Adverse reactions that are officially classified as common (reported in 2% to 5% of individuals in clinical studies) primarily involve the gastrointestinal system, but also include effects on the nervous and urinary systems.

System-Organ Class Common Adverse Reactions
Gastrointestinal Disorders Nausea, Constipation, Stomach cramps
Nervous System Disorders Headache
Renal and Urinary Disorders Increased urination

Other adverse effects documented in safety reports include flatulence, joint pain, and increased diarrhea. Official sources have reported no serious adverse events attributed to Enteragam in clinical trials or post-marketing surveillance.

Safety Considerations and Restrictions

The main safety restriction for Enteragam is a specific contraindication due to its source material. The product is strictly contraindicated in any patient with a known allergy to beef protein or any other ingredient in the formulation, such as dextrose or sunflower lecithin. Allergic manifestations, including shortness of breath or rash, while rare, necessitate this strict exclusion.

For specific populations, formal clinical studies have not been performed in pregnant women or nursing mothers. Therefore, administration in these groups is a decision left solely to the clinical judgment of the prescribing physician. No age-specific safety concerns have been identified that limit its use in older adults or children aged two years and older. Furthermore, the official safety documentation places no formal restriction on the duration of therapy.

Overdose and Emergency Response

Overdose and When to Seek Help

Due to its classification as an Oral Medical Food and its non-systemic action primarily within the gastrointestinal lumen, the official regulatory documentation for Enteragam does not describe a classic systemic overdose syndrome. Consequently, there is no formally documented presentation of systemic toxicity or organ impairment associated with acute over-ingestion.

The greatest safety concern documented in the prescribing information is the potential for a Severe Hypersensitivity Reaction (e.g., anaphylaxis). This risk is due to the active component being a serum-derived bovine protein isolate.

Element Official Safety Guidance
Documented Manifestations Non-severe, dose-related adverse events may include mild constipation, nausea, and abdominal cramps.
Life-Threatening Outcome Severe Hypersensitivity Reaction.
Immediate Action Required Seek immediate medical attention or contact a healthcare professional right away.
Trigger for Urgent Help Occurrence of severe signs, such as shortness of breath or trouble breathing.

Antidote and Management: The official label does not document the existence of a specific antidote, nor does it mandate specific procedural interventions or extended hospital monitoring requirements for acute over-ingestion.

Therapeutic Uses of Enteragam

What Enteragam Treats: Main Uses and Benefits

Enteragam is commonly used across therapeutic domains involving intestinal disorders (enteropathy) in patients who may require additional symptomatic support due to chronic medical needs. The product is relevant for conditions where functional stability becomes affected and specific nutritional support is appropriate. This product is commonly applied in scenarios where additional management of discomfort is required, helping to address symptom patterns associated with Diarrhea-predominant Irritable Bowel Syndrome (IBS-D), chronic loose stools, and certain forms of enteropathy like HIV-associated enteropathy. The aim is to provide supportive therapeutic benefit that helps manage the symptoms associated with the underlying disorder. This helps ease the symptomatic burden when manifestations interfere with daily functioning.


Quick Fact: Supportive Management of GI Symptoms

Symptom Domain Key Benefit
Chronic Diarrhea / Loose Stools Contributes to easing the overall symptom load associated with stool frequency.
Abdominal Discomfort / Bloating Contributes to improved comfort and stability.
Functional Stress May assist with maintaining functional stability during episodes of heightened discomfort.

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Enteragam — Official Regulatory Information

The eligibility profile for Enteragam, a prescription-only Oral Medical Food, is defined by specific population rules documented in official regulatory labeling.

Eligibility Scope Details from Official Regulatory Documents
Populations for whom use is allowed Adults, adolescents, and children 2 years of age and older. Use is permitted only under the supervision of a physician for clinical dietary management.
Populations for whom use is contraindicated Patients with a known allergy to beef protein or any other component of the product.
Age-related eligibility rules Use in children younger than 2 years of age is not established; use must be determined by the supervising physician. No specific geriatric problems have been documented.
Pregnancy and lactation eligibility status Use not studied in pregnant women or nursing mothers. The decision to administer is left to the clinical discretion of the supervising physician.

Connection to the Overall Eligibility Profile

Official documents define eligibility primarily through one absolute contraindication: exclusion for patients with a beef allergy due to the bovine source of the active ingredient. Eligibility for infants and individuals who are pregnant or nursing is subject to special consideration due to the documented lack of specific study data, requiring physician determination before use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interaction Scope

The official regulatory profile for Enteragam, a Serum-derived Bovine Immunoglobulin (SBI) product, is characterized by its non-systemic mechanism of action. Because the active component acts solely within the gastrointestinal lumen and is not absorbed into the bloodstream, it does not participate in systemic drug metabolism pathways.

Category Official Regulatory Statement
Systemic Drug-Drug Interactions None reported with any medicinal product.
Pharmacokinetic Interactions (e.g., CYP) Not applicable, as the product is non-systemic and does not affect systemic enzyme activity.
Exposure-Modifying Substances No substances are documented to alter the plasma levels or clearance of the product.

Administration-Related Substance Restrictions

While there are no reported systemic drug interactions, the regulatory information includes mandatory constraints regarding how the powder is mixed, designed to preserve the stability of the active proteins.

Category Restriction
Mixing Liquids to Avoid Hot liquids, citrus juice, and carbonated beverages must be avoided during reconstitution of the powder.
Timing-Based Rules The mixed product must be consumed immediately after preparation; storage of the suspension is prohibited.
Food Context May be administered with or without food.

Conclusion of Interaction Profile

The product's official interaction profile is defined by an absence of systemic drug-drug interactions. The primary interaction-related constraints are administrative, ensuring the product's physical integrity prior to intake.

Mechanism of Action

How Enteragam Works

The active component, Serum-derived Bovine Immunoglobulin (SBI), operates as a localized, non-systemic agent with a multi-faceted mechanism, primarily focused on modulating the intestinal environment and barrier function.


Targeted Luminal Neutralization

The mechanism begins in the gastrointestinal lumen where the highly concentrated Immunoglobulin G (IgG) fraction directly engages in binding and neutralization of problematic luminal factors. It primarily targets substances like Pathogen-Associated Molecular Patterns (PAMPs) and microbial toxins, such as Lipopolysaccharide (LPS) (Endotoxin). This physical interaction sequesters these irritants, resulting in their steric exclusion and preventing their translocation across the gut wall.


Epithelial Barrier Stabilization

As a consequence of reduced antigen exposure, and through the provision of essential protein factors, the mechanism supports the structural and functional integrity of the intestinal epithelial barrier. The process aids in the maintenance and proper expression of Tight Junction proteins (e.g., ZO-1), which regulate the seal between cells. The resulting physiological effect is a reduction in intestinal permeability, which supports the maintenance of the gut's selective filtering capability.


Modulation of Localized Immune Homeostasis

By preventing inflammatory and antigenic material from crossing the fortified barrier, the mechanism indirectly modulates localized immune activation within the underlying Gut-Associated Lymphoid Tissue (GALT). This action reduces the chronic, low-grade release of pro-inflammatory cytokines (e.g., TNF-alpha) in the gut wall, thereby contributing to the modulation of mucosal immune signaling. The full functional effect of this restorative mechanism becomes evident over a period of weeks, reflecting the time required for structural barrier regeneration.

Dosage and Administration Information

The administration of Enteragam (Serum-derived Bovine Immunoglobulin/Protein Isolate, SBI) is governed by the official prescribing information, which outlines the required oral route, dosing schedule, and preparation requirements. It is supplied as a powder for oral suspension, with each packet containing 5 grams of SBI.


Official Administration and Dosing

The standard regimen for adults involves taking one packet (5 g) daily. The dose may be increased, based on professional determination, up to a maximum of four packets (20 g) per day. This total daily dose is typically administered either as a single dose or divided into two doses. The product is intended for continuous, long-term use, and documentation does not impose mandatory restrictions on the duration of therapy. For children aged 2 years and older, the official labeled regimen is generally one-half packet per day, administered as a single dose or in divided doses.


Preparation and Use Guidelines

To prepare the product, the powder must be mixed with at least 4 ounces (approx 120 mL) of liquid (such as water or juice) or a soft food (like yogurt or pudding). The mixture must be stirred until fully dissolved; the official instructions advise against shaking. Administration may occur with or without food. A critical procedural constraint is that the powder must not be mixed with hot liquids or carbonated beverages to preserve the product's integrity. The prepared suspension or mixture must be consumed immediately and should not be stored.

Recent Clinical Evidence

Enteragam: Recent Clinical Evidence

Enteragam (serum-derived bovine immunoglobulin/protein isolate, SBI) is a medical food product investigated for the dietary management of chronic diarrhea and loose stools associated with specific intestinal disorders, such as diarrhea-predominant irritable bowel syndrome (IBS-D).


Investigation of Action and Efficacy

Clinical studies have explored the role of SBI in the gastrointestinal tract, noting that the concentrated immunoglobulins may bind to microbial components and toxins. This action is believed to aid in maintaining the gut barrier function and promoting gut immune balance, which are often impaired in individuals with chronic intestinal issues.

Key research includes a randomized, double-blind, placebo-controlled study in adults with IBS-D. This trial reported that participants experienced a reduction in the number of days per week with loose stools and other gastrointestinal symptoms, including abdominal pain and urgency, compared to baseline measures. While the study suggested a distinctive nutritional effect, results varied among different patient groups.


Safety and Tolerability

The tolerability of SBI has been evaluated across various studies, including those lasting up to 52 weeks. The product acts locally within the gastrointestinal tract and is not absorbed systemically. The most common adverse events reported in clinical trials (incidence of 2% to 5%) included mild nausea, constipation, stomach cramps, and headache. Discontinuation rates due to adverse events were reported to be low and similar between the treatment and placebo groups in the primary IBS-D study. SBI contains beef protein and is contraindicated for use in patients with a known allergy to beef or any other component of the product. Data regarding use during pregnancy or nursing are limited.

Key Studies & References

  1. Evaluation of oral serum-derived bovine immunoglobulins in HIV-infected patients with chronic idiopathic diarrhea
  2. EnteraGam Prescribing Information/Package Insert (Medical Food Label)

Frequently Asked Questions (FAQ)

Common questions about Enteragam (FAQ)


Q: Is Enteragam a probiotic or a different kind of supplement?

According to official documentation, Enteragam is classified as a prescription medical food. This classification means it is specially formulated for the clinical dietary management of a specific condition under the supervision of a physician. It is a category distinct from standard dietary supplements or probiotics.


Q: Is Enteragam used in children or only adults?

Official information confirms that the product is indicated for use in both adults and children aged 2 years and older. However, its use is permitted only under the supervision of a physician for clinical dietary management.


Q: Can Enteragam be mixed with hot liquids?

No. The official preparation guidelines advise that the powder must not be mixed with hot liquids. This constraint is in place because the high temperature may cause the active proteins in the product to degrade, compromising its stability and intended function.


Q: What should be done if a user suspects an allergic reaction to Enteragam?

If there is any suspicion of an allergic manifestation, such as shortness of breath or rash, any suspected allergic manifestation necessitates immediate cessation of the product. Due to the strict contraindication for patients with a known beef protein allergy, a healthcare professional must be consulted promptly.


Q: Can Enteragam be taken for issues other than those listed on the label?

The product is officially labeled as a medical food intended only for the clinical dietary management of chronic diarrhea and loose stools associated with specific intestinal disorders. As it is a prescription-only product, its use is restricted to the specific purposes outlined in the official regulatory documentation.


Q: Is Enteragam the same as serum-derived bovine immunoglobulin (SBI)?

Yes, serum-derived bovine immunoglobulin/protein isolate (SBI) is the active, core functional component contained within the Enteragam product. The formulation delivers a highly purified and concentrated form of this protein isolate to the gastrointestinal tract.


Q: What is the main difference between Enteragam and regular immune supplements?

Enteragam holds the regulatory designation of a prescription medical food, which sets it apart from non-prescription immune or dietary supplements. This classification means the product is formulated to meet distinctive nutritional requirements that can only be met under a physician's supervision for the management of a specific disease or condition.


Q: Are there any long-term effects of taking Enteragam?

Official regulatory documentation states that the product is intended for continuous, long-term use under medical supervision. The labeling does not impose a mandatory restriction on the total duration of therapy, and the appropriateness of extended therapy is determined by a supervising physician.


Q: How quickly should someone expect to notice anything after starting Enteragam?

Studies and official information indicate that the full functional effect of the product's mechanism typically becomes evident over a period of 2 to 4 weeks after starting use. Optimal results depend on adherence to the regimen prescribed by the physician.


Q: Can Enteragam cause weight gain or weight loss?

Weight gain or weight loss are not listed as common adverse reactions (reported in 2% to 5% of users) in the official regulatory safety profile. The most frequently documented non-serious effects relate primarily to the gastrointestinal system, such as nausea or stomach cramps.


Q: Does Enteragam change how the body absorbs vitamins or nutrients?

The product's non-systemic mechanism of action, which involves modulating the gut barrier, is described in evidence as supporting intestinal absorption and utilization of certain nutrients. It focuses on optimizing the gut environment rather than acting on systemic metabolism.


Q: Are there specific symptoms that mean Enteragam might not be working?

Clinical effectiveness is typically measured by observed changes in the symptoms the product is intended to manage. This includes a reduction in the frequency of loose stools and other related gastrointestinal discomforts. A lack of change in these core symptoms over time may indicate limited effectiveness.


Q: What happens if I accidentally miss a serving of Enteragam?

The official instructions advise taking the dose as soon as possible if it is missed. However, if it is almost time for the next scheduled dose, the official instructions indicate that the missed dose should be skipped entirely. It is strictly advised to not double the dose to make up for a missed one.


Q: Does Enteragam need to be refrigerated, or how should it be stored?

Official guidance states that the product must be stored in a closed container at room temperature, away from heat, moisture, and direct light. It is a critical requirement to keep the product from freezing.


Q: Can Enteragam affect the results of blood tests?

Regulatory documents indicate that the product acts as a non-systemic agent, meaning it functions primarily within the gut lumen. Because of this, it is non-systemic and is therefore not known to interfere with systemic drug metabolism or blood test results.


Q: Does Enteragam have any interactions with common pain relievers like Tylenol (acetaminophen)?

Official regulatory information reports no systemic drug-drug interactions with any medicinal product, including common pain relievers. This is due to the product's mechanism of action, which is confined to the gastrointestinal tract and does not involve systemic enzyme activity.


Q: If I already take a multivitamin, does Enteragam interact with it?

No systemic drug-drug interactions have been reported. However, the product's mechanism is associated with supporting the utilization and absorption of certain nutrients in the gut. Any specific concerns about concurrent vitamin or nutrient intake are best clarified with a prescribing physician.


Q: Can Enteragam change the color or frequency of bowel movements?

Changes in bowel movement frequency are noted in the adverse reaction profile, which includes reports of constipation and increased diarrhea. Changes to the color of bowel movements are not documented as common or other adverse reactions in official safety information.


Q: Does Enteragam contain sugar or artificial sweeteners?

The formulation contains Agglomerated Dextrose as an ingredient, which is a form of sugar. Official product information also states that the product is free from dye and soy ingredients.


Q: Is there any official guidance on taking Enteragam with high-fat meals?

The official instructions state that the product may be administered with or without food. Regulatory documentation does not specify any restrictions or special guidance regarding the fat or calorie content of the accompanying meal.


Q: Are there any known interactions between Enteragam and common acid-reducing medications?

Official documents report no systemic drug-drug interactions with any medicinal product. The product is non-systemic, acting locally in the gut, which means it is not expected to interfere with the function or absorption of acid-reducing medications.


Q: Why is the bovine source important for Enteragam's function?

The bovine source is used to extract and purify the concentrated Immunoglobulin G (IgG) fraction. The importance lies in delivering this specific protein component to the gut lumen, where it works by binding and neutralizing problematic factors.


Q: How do doctors monitor the effectiveness of Enteragam?

Clinical studies and prescribing information indicate that effectiveness is primarily monitored by tracking changes in the physical symptoms being managed. These measures typically include the patient's reduction in the frequency of loose stools and related gastrointestinal discomfort.


Q: Does Enteragam interact with hormonal birth control pills?

Official regulatory information reports no systemic drug-drug interactions with any medicinal product, including hormonal agents like birth control pills. This is due to the product being non-systemic, meaning it is not absorbed into the bloodstream where it could interfere with hormonal metabolism.


Q: Can I take Enteragam if I am trying to become pregnant?

Official regulatory documents state that use of the product has not been studied in women who are pregnant or nursing. The decision regarding its use is subject to the clinical determination of the supervising physician due to limited data.


Q: Is there a link between Enteragam and changes in sleep patterns?

Changes in sleep patterns are not listed as a common or other documented adverse reaction in the official regulatory safety profile. The documented common side effects relate primarily to the digestive and nervous systems (headache).

How should Enteragam be stored and disposed of?

How to Store and Dispose of EnteraGam

This section outlines the official, labeled storage and disposal requirements for EnteraGam (Serum-derived Bovine Immunoglobulin) as established by regulatory documents.

Storage Requirements

EnteraGam must be stored in a closed container at room temperature. Protection is mandatory against environmental factors: the product must be kept away from heat, moisture, and direct light, and it is strictly required to keep from freezing. For safety, the medicine must be stored out of the reach of children.

Stability and Disposal

Once mixed with liquid or soft food, the preparation should be consumed immediately. Official guidance instructs consumers not to keep outdated or unneeded medicine. For disposal, consumers must ask their healthcare professional how to dispose of any unused product. Regulations also advise against letting the product enter drains.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Enteragam found in:

A-Z Index: